{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:08:17Z","timestamp":1783822097337,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40261-026-01569-5","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:26:35Z","timestamp":1781097995000},"page":"897-909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Change in Adherence to Oral Antidiabetic Medications Before and After Prostate Cancer Diagnosis: A Group-Based Trajectory Modeling Approach"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5133-265X","authenticated-orcid":false,"given":"Ahmed S.","family":"Kenawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1236-6264","authenticated-orcid":false,"given":"James O.","family":"Baffoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-0950","authenticated-orcid":false,"given":"Chanhyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"1569_CR1","unstructured":"Key Statistics for Prostate Cancer | Prostate Cancer Facts [Internet]. [cited 2025 May 6]. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html. Accessed 6 May 2025"},{"key":"1569_CR2","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s10552-008-9198-6","volume":"19","author":"MF Leitzmann","year":"2008","unstructured":"Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang S-C, et al. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control. 2008;19:1267\u201376. https:\/\/doi.org\/10.1007\/s10552-008-9198-6.","journal-title":"Cancer Causes Control"},{"key":"1569_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10552-013-0334-6","volume":"25","author":"L Bensimon","year":"2014","unstructured":"Bensimon L, Yin H, Suissa S, Pollak MN, Azoulay L. Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control. 2014;25:329\u201338. https:\/\/doi.org\/10.1007\/s10552-013-0334-6.","journal-title":"Cancer Causes Control"},{"key":"1569_CR4","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1158\/1055-9965.EPI-22-1324","volume":"32","author":"A Sergeyev","year":"2023","unstructured":"Sergeyev A, Gu L, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, et al. Diabetes and prostate cancer outcomes in men with nonmetastatic castration-resistant prostate cancer: results from the SEARCH Cohort. Cancer Epidemiol Biomarkers Prev. 2023;32:1208\u201316. https:\/\/doi.org\/10.1158\/1055-9965.EPI-22-1324.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1569_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.diabres.2018.03.011","volume":"139","author":"L L\u00e9tinier","year":"2018","unstructured":"L\u00e9tinier L, Mansiaux Y, Pariente A, Fourrier-R\u00e9glat A. Impact of cancer diagnosis on persistence of oral antidiabetic drugs. Diabetes Res Clin Pract. 2018;139:323\u201330. https:\/\/doi.org\/10.1016\/j.diabres.2018.03.011.","journal-title":"Diabetes Res Clin Pract"},{"key":"1569_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1185\/03007995.2011.570745","volume":"27","author":"V Hutchins","year":"2011","unstructured":"Hutchins V, Zhang B, Fleurence RL, Krishnarajah G, Graham J. A systematic review of adherence, treatment satisfaction, and costs, in fixed-dose combination regimens in type 2 diabetes. Curr Med Res Opin. 2011;27:1157\u201368. https:\/\/doi.org\/10.1185\/03007995.2011.570745.","journal-title":"Curr Med Res Opin"},{"key":"1569_CR7","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1016\/j.jval.2023.03.1064","volume":"26","author":"S Gohil","year":"2023","unstructured":"Gohil S, Johnson ML, Goyal R. EPH183 impact of a cancer diagnosis on non-cancer chronic disease medication adherence\u2014a systematic literature review. Value Health. 2023;26:S197. https:\/\/doi.org\/10.1016\/j.jval.2023.03.1064.","journal-title":"Value Health"},{"key":"1569_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jgo.2020.04.012","volume":"12","author":"JL Lund","year":"2021","unstructured":"Lund JL, Gupta P, Amin KB, Meng K, Urick BY, Reeder-Hayes KE, et al. Changes in chronic medication adherence in older adults with cancer versus matched cancer-free cohorts. J Geriatr Oncol. 2021;12:72\u20139. https:\/\/doi.org\/10.1016\/j.jgo.2020.04.012.","journal-title":"J Geriatr Oncol"},{"key":"1569_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071117","volume":"17","author":"M-H Jung","year":"2025","unstructured":"Jung M-H, Jung M-K, Kim E-S, Youn J-C, Lee EY, Kang D, et al. Adherence to antidiabetic medication and cardiovascular outcomes in cancer patients: a nationwide population-based cohort study. Cancers (Basel). 2025;17:1117. https:\/\/doi.org\/10.3390\/cancers17071117.","journal-title":"Cancers (Basel)"},{"key":"1569_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1210\/clinem\/dgad450","volume":"109","author":"S Harborg","year":"2024","unstructured":"Harborg S, Kj\u00e6rgaard KA, Thomsen RW, Borgquist S, Cronin-Fenton D, Hjorth CF. New horizons: epidemiology of obesity, diabetes mellitus, and cancer prognosis. J Clin Endocrinol Metab. 2024;109:924\u201335. https:\/\/doi.org\/10.1210\/clinem\/dgad450.","journal-title":"J Clin Endocrinol Metab"},{"key":"1569_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.clgc.2016.08.020","volume":"15","author":"NG Zaorsky","year":"2017","unstructured":"Zaorsky NG, Shaikh T, Ruth K, Sharda P, Hayes SB, Sobczak ML, et al. Prostate cancer patients with unmanaged diabetes or on insulin have worse outcomes and toxicities after treatment with radiation therapy. Clin Genitourin Cancer. 2017;15:326-335.e3. https:\/\/doi.org\/10.1016\/j.clgc.2016.08.020.","journal-title":"Clin Genitourin Cancer"},{"key":"1569_CR12","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51:S11. https:\/\/doi.org\/10.1097\/MLR.0b013e31829b1d2a.","journal-title":"Med Care"},{"key":"1569_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000360229","volume":"65","author":"DS Nagin","year":"2014","unstructured":"Nagin DS. Group-based trajectory modeling: an overview. Ann Nutr Metab. 2014;65:205\u201310. https:\/\/doi.org\/10.1159\/000360229.","journal-title":"Ann Nutr Metab"},{"key":"1569_CR14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jamaoncol.2016.1291","volume":"2","author":"AI Neugut","year":"2016","unstructured":"Neugut AI, Zhong X, Wright JD, Accordino M, Yang J, Hershman DL. Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer. JAMA Oncol. 2016;2:1326\u201332. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1291.","journal-title":"JAMA Oncol"},{"key":"1569_CR15","doi-asserted-by":"publisher","first-page":"e1475","DOI":"10.1200\/OP.22.00008","volume":"18","author":"J Gatwood","year":"2022","unstructured":"Gatwood J, Dashputre A, Rajpurohit A, Gatwood K, Mackler E, Wallace L, et al. Medication adherence among adults with comorbid chronic conditions initiating oral anticancer agent therapy for multiple myeloma. JCO Oncol Pract. 2022;18:e1475\u201383. https:\/\/doi.org\/10.1200\/OP.22.00008.","journal-title":"JCO Oncol Pract."},{"key":"1569_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/10781552231171926","volume":"30","author":"J Gatwood","year":"2024","unstructured":"Gatwood J, Dashputre A, Rajpurohit A, Gatwood K, Mackler E, Wallace L, et al. Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions. J Oncol Pharm Pract. 2024;30:342\u201353. https:\/\/doi.org\/10.1177\/10781552231171926.","journal-title":"J Oncol Pharm Pract"},{"key":"1569_CR17","doi-asserted-by":"publisher","first-page":"e800","DOI":"10.1200\/JOP.2016.011742","volume":"12","author":"J Yang","year":"2016","unstructured":"Yang J, Neugut AI, Wright JD, Accordino M, Hershman DL. Nonadherence to oral medications for chronic conditions in breast cancer survivors. J Oncol Pract. 2016;12:e800-809. https:\/\/doi.org\/10.1200\/JOP.2016.011742.","journal-title":"J Oncol Pract"},{"key":"1569_CR18","unstructured":"Real world evidence | Merative [Internet]. [cited 2025 Apr 21]. https:\/\/www.merative.com\/real-world-evidence. Accessed 21 Apr 2025"},{"key":"1569_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1089\/wound.2013.0478","volume":"2","author":"DJ Cartwright","year":"2013","unstructured":"Cartwright DJ. ICD-9-CM to ICD-10-CM codes: what? Why? How? Adv Wound Care. 2013;2:588\u201392. https:\/\/doi.org\/10.1089\/wound.2013.0478.","journal-title":"Adv Wound Care"},{"key":"1569_CR20","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1111\/bcp.15391","volume":"88","author":"LL Dalli","year":"2022","unstructured":"Dalli LL, Kilkenny MF, Arnet I, Sanfilippo FM, Cummings DM, Kapral MK, et al. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: a scoping review and new tool TEN\u2010SPIDERS. Br J Clin Pharmacol. 2022;88:4427\u201342. https:\/\/doi.org\/10.1111\/bcp.15391.","journal-title":"Br J Clin Pharmacol"},{"key":"1569_CR21","unstructured":"Pharmacy Quality Alliance: Adherence Measures [Internet]. [cited 2025 Apr 21]. https:\/\/www.pqaalliance.org\/adherence-measures. Accessed 21 Apr 2025"},{"key":"1569_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0620-9","volume":"18","author":"J Elmer","year":"2018","unstructured":"Elmer J, Jones BL, Nagin DS. Using the Beta distribution in group-based trajectory models. BMC Med Res Methodol. 2018;18:152. https:\/\/doi.org\/10.1186\/s12874-018-0620-9.","journal-title":"BMC Med Res Methodol"},{"key":"1569_CR23","doi-asserted-by":"publisher","DOI":"10.4159\/9780674041318","volume-title":"Model selection. Group-based modeling of development","author":"D Nagin","year":"2005","unstructured":"Nagin D. Model selection. Group-based modeling of development. Cambridge: Harvard University Press; 2005."},{"key":"1569_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338. https:\/\/doi.org\/10.1146\/annurev.clinpsy.121208.131413.","journal-title":"Annu Rev Clin Psychol"},{"key":"1569_CR25","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.9.1138","volume":"26","author":"M Alhazami","year":"2020","unstructured":"Alhazami M, Pontinha VM, Patterson JA, Holdford DA. Medication adherence trajectories: a systematic literature review. J Manag Care Spec Pharm. 2020;26:10.18553\/jmcp.2020.26.9.1138. https:\/\/doi.org\/10.18553\/jmcp.2020.26.9.1138.","journal-title":"J Manag Care Spec Pharm"},{"key":"1569_CR26","doi-asserted-by":"crossref","unstructured":"Nagin D. Posterior group-membership probabilities. Group-based modeling of development. Cambridge: Harvard University Press; 2005.","DOI":"10.4159\/9780674041318"},{"key":"1569_CR27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83.","journal-title":"Med Care"},{"key":"1569_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/PROM.S52788","volume":"5","author":"H Ahmadi","year":"2014","unstructured":"Ahmadi H, Daneshmand S. Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes. Patient Relat Outcome Meas. 2014;5:63\u201370. https:\/\/doi.org\/10.2147\/PROM.S52788.","journal-title":"Patient Relat Outcome Meas"},{"key":"1569_CR29","unstructured":"traj: group-based modeling of longitudinal data [Internet]. [cited 2025 Apr 23]. https:\/\/www.andrew.cmu.edu\/user\/bjones\/. Accessed 23 Apr 2025"},{"key":"1569_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0049124106292292","volume":"35","author":"T Loughran","year":"2006","unstructured":"Loughran T, Nagin DS. Finite sample effects in group-based trajectory models. Sociol Methods Res. 2006;35:250\u201378. https:\/\/doi.org\/10.1177\/0049124106292292.","journal-title":"Sociol Methods Res"},{"key":"1569_CR31","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1111\/bcp.14075","volume":"85","author":"CA Walsh","year":"2019","unstructured":"Walsh CA, Cahir C, Tecklenborg S, Byrne C, Culbertson MA, Bennett KE. The association between medication non\u2010adherence and adverse health outcomes in ageing populations: a systematic review and meta\u2010analysis. Br J Clin Pharmacol. 2019;85:2464\u201378. https:\/\/doi.org\/10.1111\/bcp.14075.","journal-title":"Br J Clin Pharmacol"},{"key":"1569_CR32","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s11764-018-0716-6","volume":"12","author":"MP Banegas","year":"2018","unstructured":"Banegas MP, Emerson MA, Adams AS, Achacoso NS, Chawla N, Alexeeff S, et al. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer. J Cancer Surviv. 2018;12:794\u2013802. https:\/\/doi.org\/10.1007\/s11764-018-0716-6.","journal-title":"J Cancer Surviv"},{"key":"1569_CR33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00125-015-3497-8","volume":"58","author":"MMJ Zanders","year":"2015","unstructured":"Zanders MMJ, Haak HR, van Herk-Sukel MPP, van de Poll-Franse LV, Johnson JA. Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes. Diabetologia. 2015;58:951\u201360. https:\/\/doi.org\/10.1007\/s00125-015-3497-8.","journal-title":"Diabetologia"},{"key":"1569_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-clinpsy-081122-012416","volume":"20","author":"DS Nagin","year":"2024","unstructured":"Nagin DS, Jones BL, Elmer J. Recent advances in group-based trajectory modeling for clinical research. Annu Rev Clin Psychol. 2024;20:285\u2013305. https:\/\/doi.org\/10.1146\/annurev-clinpsy-081122-012416.","journal-title":"Annu Rev Clin Psychol"},{"key":"1569_CR35","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1002\/cncr.33147","volume":"126","author":"LP Spees","year":"2020","unstructured":"Spees LP, Wheeler SB, Zhou X, Amin KB, Baggett CD, Lund JL, et al. Changes in Chronic medication adherence, costs, and healthcare utilization after a cancer diagnosis among low-income patients and the role of patient-centered medical homes. Cancer. 2020;126:4770\u20139. https:\/\/doi.org\/10.1002\/cncr.33147.","journal-title":"Cancer"},{"key":"1569_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4280-1","volume":"19","author":"S Morrell","year":"2019","unstructured":"Morrell S, Young J, Roder D. The burden of cancer on primary and secondary health care services before and after cancer diagnosis in New South Wales, Australia. BMC Health Serv Res. 2019;19:431. https:\/\/doi.org\/10.1186\/s12913-019-4280-1.","journal-title":"BMC Health Serv Res"},{"key":"1569_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11892-023-01532-0","volume":"24","author":"K Gow","year":"2024","unstructured":"Gow K, Rashidi A, Whithead L. Factors influencing medication adherence among adults living with diabetes and comorbidities: a qualitative systematic review. Curr Diab Rep. 2024;24:19\u201325. https:\/\/doi.org\/10.1007\/s11892-023-01532-0.","journal-title":"Curr Diab Rep"},{"key":"1569_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2020.103727","volume":"110","author":"A Rashidi","year":"2020","unstructured":"Rashidi A, Kaistha P, Whitehead L, Robinson S. Factors that influence adherence to treatment plans amongst people living with cardiovascular disease: a review of published qualitative research studies. Int J Nurs Stud. 2020;110:103727. https:\/\/doi.org\/10.1016\/j.ijnurstu.2020.103727.","journal-title":"Int J Nurs Stud"},{"key":"1569_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6181-4","volume":"19","author":"CL Niedzwiedz","year":"2019","unstructured":"Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19:943. https:\/\/doi.org\/10.1186\/s12885-019-6181-4.","journal-title":"BMC Cancer"},{"key":"1569_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260358","volume":"16","author":"JG Trogdon","year":"2021","unstructured":"Trogdon JG, Amin K, Gupta P, Urick BY, Reeder-Hayes KE, Farley JF, et al. Providers\u2019 mediating role for medication adherence among cancer survivors. PLoS ONE. 2021;16:e0260358. https:\/\/doi.org\/10.1371\/journal.pone.0260358.","journal-title":"PLoS ONE"},{"key":"1569_CR41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/MLR.0000000000001625","volume":"59","author":"RP Hickson","year":"2021","unstructured":"Hickson RP, Annis IE, Killeya-Jones LA, Fang G. Comparing continuous and binary group-based trajectory modeling using statin medication adherence data. Med Care. 2021;59:997\u20131005. https:\/\/doi.org\/10.1097\/MLR.0000000000001625.","journal-title":"Med Care"},{"key":"1569_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10549-016-4043-1","volume":"161","author":"GS Calip","year":"2017","unstructured":"Calip GS, Elmore JG, Boudreau DM. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. Breast Cancer Res Treat. 2017;161:161\u201372. https:\/\/doi.org\/10.1007\/s10549-016-4043-1.","journal-title":"Breast Cancer Res Treat"},{"key":"1569_CR43","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1016\/j.jval.2023.03.1011","volume":"26","author":"S Han","year":"2023","unstructured":"Han S, Ng BP, Park C. EPH129 comorbidity patterns among older women with breast cancer: a 10-year cohort study using an unsupervised machine learning approach. Value Health. 2023;26:S187. https:\/\/doi.org\/10.1016\/j.jval.2023.03.1011.","journal-title":"Value Health"},{"key":"1569_CR44","doi-asserted-by":"publisher","first-page":"880","DOI":"10.62347\/NWHM4133","volume":"14","author":"TA Ahmad","year":"2024","unstructured":"Ahmad TA, Dayem Ullah AZ, Chelala C, Gopal DP, Eto F, Henkin R. Prevalence of multimorbidity in survivors of 28 cancer sites: an English nationwide cross-sectional study. Am J Cancer Res. 2024;14:880\u201396. https:\/\/doi.org\/10.62347\/NWHM4133.","journal-title":"Am J Cancer Res"},{"key":"1569_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.38039","volume":"6","author":"G Ciccone","year":"2023","unstructured":"Ciccone G, De Luca S, Oderda M, Munoz F, Krengli M, Allis S, et al. Patient and context factors in the adoption of active surveillance for low-risk prostate cancer. JAMA Netw Open. 2023;6:e2338039. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.38039.","journal-title":"JAMA Netw Open"},{"key":"1569_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/jac5.1771","volume":"6","author":"KK Shah","year":"2023","unstructured":"Shah KK, Touchette DR, Marrs JC. Research and scholarly methods: measuring medication adherence. JACCP. 2023;6:416\u201326. https:\/\/doi.org\/10.1002\/jac5.1771.","journal-title":"JACCP"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01569-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:02:06Z","timestamp":1783821726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-026-01569-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01569-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ahmed S Kenawy, James O Baffoe, and Chanhyun Park have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Access to the data supporting this study's findings (MarketScan Commercial and Medicare supplemental databases) is strictly limited to members of the research team who signed the Data Use Agreement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"We obtained exempt approval to conduct this study from the Institutional Review Board (IRB) of the University of Texas at Austin. The IRB determined this study to be a secondary use of a de-identified data set with no direct links to identifiers (IRB ID: STUDY00007413).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Conceptualization: AK and CP; Methodology: AK and CP; formal analysis and investigation: AK; writing\u2014original draft preparation: AK, JB, and CP; writing\u2014review and editing: AK, JB, and CP; Supervision: CP. All authors read and approved the final version and agree to be accountable for the work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}